Search Results

Showing results 1-10 of 28 for 'blood'

  • Idit Shachar
    Target: Blood Cancers

    Read about Prof. Idit Shachar's search for an improved treatment for chronic lymphocytic leukemia and other blood cancers. She and her team discovered a blocking antibody that showed great promise in killing cancer cells in a clinical trial. Prof. Shachar also addresses the challenges of being a woman (and mom) in science. This is WeizmannViews Issue No. 45.

  • Alon_T cell makes holes_01_17
    White Blood Cells Get Pushy to Reach Infection

    How do white blood cells - the immune cells that race to the sites of infection and inflammation - actually get to their targets? The research of Prof. Ronen Alon has revealed that the white blood cells actually force their way through the blood vessel walls to reach the infection, creating large holes. This understanding could aid in cancer research.

  • immune cells_cosmos article
    How Immune Cells Squeeze Through Blood Vessel Walls

    Cosmos reports on new research from Prof. Ronen Alon’s lab that reveals how immune cells enter - and leave - the bloodstream. It has long been known that they can do this, but not how. The findings are particularly relevant to cancer research, as tumor cells are less able to infiltrate the bloodstream.

  • Dr. Karina Yaniv to be honored with LE&RN’s 2016 Wendy Chaite Leadership Award

    The Lymphatic Education & Research Network has announced that it is awarding its prestigious Wendy Chaite Leadership Award to Weizmann’s Dr. Karina Yaniv. With funding support from the organization, Dr. Yaniv recently showed – for the first time – how the lymphatic system develops. The award will be presented on March 23 by actor Kathy Bates.

  • Lymphedema: What It is, What’s Being Done About It, and How You Can Help

    Lymphedema is a too-unknown condition involving severe swelling that affects about 10 million Americans, most of them cancer survivors. Learn what lymphedema is and about the research and organizations that are trying to help – and sign a petition at to establish World Lymphedema Day.

  • Cell Source's Megadose Drug Combination Treats First Patient

    Cell Source, the biotech firm that is developing Prof. Yair Reisner’s “megadose” stem cell therapy, announced that the first cancer patient appears to have been successfully treated. The treatment allows bone marrow transplants between mismatched donors and patients, reducing levels of rejection and increasing rates of success and survival.

  • Rethinking Lymphatic Development

    Lymphatic vessels were first described by Hippocrates; centuries later, we’re still learning about them. Weizmann’s Dr. Karina Yaniv recently discovered that the lymphatic system does not develop as previously thought. Interestingly, says The Scientist, after all these years, three other studies on lymph vessel origin came out at the same time.

  • Kathy Bates: My Battle with Lymphedema

    Oscar winner Kathy Bates opens up to Larry King about developing lymphedema – which occurs when the lymph nodes are removed or blocked – after a double mastectomy. Now a lymphedema activist raising awareness and funds, she gets hope from research like Dr. Karina Yaniv’s, whose breakthroughs include being the first to grow lymphatic cells in the lab.

  • Resolving a Lymphatic Riddle

    For more than a century, scientists have debated how the lymphatic system arises. Now that question has been answered, as Weizmann’s Dr. Karina Yaniv has revealed how the system develops in the embryo, and – in a world’s first – grown lymphatic cells in the lab. Besides solving this long-standing puzzle, her work can provide important insights into disease.

  • Scientists Identify the Signature of an Aging Brain

    There is much about our brains that we still do not know, including how it is impacted by aging. But now, as The Jerusalem Post reports, the Weizmann Institute’s Prof. Michal Schwartz and Dr. Ido Amit have “found evidence of a unique ‘signature’ that may be the ‘missing link’ between cognitive decline and aging.” This discovery could someday lead to treatments to slow or reverse the process.